Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 691-696

  Yu, Aimee Y ^a   Shimoda, Larissa A ^a   Iyer, Narayan V ^a   Huso, David L ^a   Sun, Xing ^a   McWilliams, Rita ^b   Beaty, Terri ^b   Sham, James S K ^a   Wiener, Charles M ^a   Sylvester, J T ^a   Semenza, Gregg L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLYCOLYTIC ENZYME; HELIX LOOP HELIX PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; EMBRYO DEVELOPMENT; GENETIC TRANSCRIPTION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; MOUSE; NONHUMAN; POLYCYTHEMIA; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; WEIGHT REDUCTION;

EID: 0033104847     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5912     Document Type: Article

References (47)

1. Hultgren, H.N., and Grover, R.F. 1968. Circulatory adaptation to high altitude. Annu. Rev. Med. 19:119-152.
2. Moraes, D., and Loscalzo, J. 1997. Pulmonary hypertension: newer concepts in diagnosis and management. Clin. Cardiol. 20:676-682.
3. Naeije, R. 1997. Pulmonary circulation at high altitude. Respiration. 64:429-434.
4. A-receptor antagonism prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am. J. Phystol. 269:L690-L697.
5. Hales, C.A., Kradin, R.L., Brandstetter, R.D., and Zhu, Y.-J. 1983. Impairment of hypoxic pulmonary artery remodeling by heparin in mice. Am. Rev. Respir. Dis. 128:747-751.
6. Li, H., et al. 1994. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J. Appl. Physiol. 77:1451-1459.
7. Ostadal, B, et al. 1978. The effect of beta adrenergic blockade on pulmonary hypertension, nght ventricular hypertrophy and polycythaemia, induced in rats by intermittent high altitude hypoxia. Basic Res. Cardiol. 73:422-432.
8. Rabinovitch, M., Gamble, W., Nades, A.S., Miettinen, O.S., and Reid, L. 1979. Rat pulmonary circulation after chronic hypoxia: hemodynamics and structural features. Am. J. Physiol. 236:H818-H827.
9. Widimsky, J., et al. 1973. Effect of intermittent altitude hypoxia on the myocardium and lesser circulation in the rat. Cardiovasc. Res. 7:798-808.
10. Steudel, W., et al. 1998. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J. Clin. Invest. 101:2468-2477.
11. Voelkel, N.F., et al. 1996. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J. Clin. Invest. 97:2491-2498.
12. Wang, G.L., and Semenza, G.L. 1996. Molecular basis of hypoxia-induced erythropoietin expression. Curr. Opin. Hematol. 3:156-162.
13. Jin, H.K., et al. 1989. Hemodynamic effects of arginine vasopressin in rats adapted to chronic hypoxia. J. Appl. Physiol. 66:151-160.
14. Jones, A.T., and Evans, T.W. 1997. NO: COPD and beyond. Thorax. 52:S16-S21.
15. Oka, M., Morris, K.G., and McMurtry, I.F. 1993. NIP-121 is more effective than nifedipine in acutely reversing chronic hypoxic pulmonary hypertension. J. Appl. Physiol. 75:1074-1080.
16. Semenza, G.L., and Wang, G.L. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447-5454.
17. 2 tension. Proc. Natl. Acad. Sci. USA. 92:5510-5514.
18. Rolfs, A., Kvietikova, I., Gassmann, M., and Wenger, R.H. 1997. Oxygenregulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272:20055-20062.
19. Forsythe, J.A., et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
20. Liu, Y., Cox, S.R. Morita, T., and Kourembanas, S. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ. Res. 77:638-643.
21. Gerber, H.-P., Condorelli, F., Park, J., and Ferrara, N. 1997. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-1, is upregulated by hypoxia. J. Biol. Chem. 272:23659-23667.
22. Melillo, G., et al. 1995. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1683-1693.
23. Palmer, L.A., Semenza, G.L., Stoler, M.H., and Johns, R.A. 1998. Hypoxia induces type II NOS gene expression in pulmonary artery endothehal cells via HIF-1. Am. J. Physiol. 274:L212-L219.
24. Lee, P.J., et al. 1997. Hypoxia-inducible factor 1 mediates transcriptional activation of heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272:5375-5381.
25. Hu, J., Discher, D.J., Bishopric, N.H., and Webster, K.A. 1998. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor 1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245:894-899.
26. Kourembanas, S., Morita, T., Liu, Y., and Christou, H. 1997. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int. 51:438-443.
27. Le Cras, T.D., Xue, C., Rengasamy, A., and Johns, R.A. 1996. Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am. J. Physiol. 270:L164-L170.
28. Ou, L.C., et al. 1998. Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness. J. Appl. Physiol. 8:1242-1251.
29. Tuder, R.M., Flook, B.E., and Voelkel, N.F. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in Kings exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798-1807.
30. Wang, G.L., and Semenza, G.L. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230-1237.
31. Jiang, B.-H., Rue, E., Wang, G.L., Roe, R., and Semenza, G.L. 1996. Dimerization, DNA binding, and transactivation properties of hypoxiainducible factor 1. J. Biol. Chem. 271:17771-17778.
32. Hoffman, E.C., et al. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science. 252:954-958.
33. 2 tension. Am. J. Physiol. 271:C1172-C1180.
34. Semenza, G.L., et al. 1998. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-mdudble factor 1. J. Biol. Chem. 271:32529-32537.
35. Martin, C., et al. Cardiac hypertrophy in chronically anemic fetal sheep: increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178:527-534.
36. Yu, A.Y., et al. 1998. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor 1 in the lung. Am. J. Physiol. 275:L818-L826.
37. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 12:149-162.
38. Ryan, H.E., Lo, J., and Johnson, R.S. 1998. HIF-1α is required for solid rumor formation and embryonic vascularizarinn. EMBO J. 17:3005-3015.
39. Semenza, G.L., Traystman, M.D., Gearhart, J.D., and Antonarakis, S.E. 1989. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc. Natl. Acad. Sci. USA. 86:2301-2305.
40. Petit, R.D., Warburton, R.R., Ou, L.C., and Hill, N.S. 1995. Pulmonary vascular adaptations to augmented polycythemia during chronic hypoxia. J. Appl. Physiol. 79:229-235.
41. Agani, F., and Semenza, G.L. 1998. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. Mol. Pharmacol. 54:749-754.
42. Zelzer, E., et al. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17:5085-5094.
43. Kim, K.W., et al. 1998. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 58:348-351.
44. Tapanainen, P.J., et al. 1997. Hypoxia-induced changes in insulin-like growth factors and their binding proteins in pregnant rats. Horm. Res. 48:227-234.
45. Tucci, M., et al. 1998. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. J. Endocrinol. 157:13-24.
46. Tazuke, S.I., et al. 1998. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. USA. 95:10188-10193.
47. Thaete, L.G., Neerhof, M.G., and Caplan, M.S. 1997. Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am. J. Obstet. Gynecol. 176:73-76.